214 related articles for article (PubMed ID: 29169984)
1. Left Main restenosis in the DES era - a call for action.
di Palma G; Cortese B
Cardiovasc Revasc Med; 2018 Jun; 19(4):466-470. PubMed ID: 29169984
[TBL] [Abstract][Full Text] [Related]
2. Difference in vascular response between sirolimus-eluting- and everolimus-eluting stents in ostial left circumflex artery after unprotected left main as observed by optical coherence tomography.
Fujino Y; Attizzani GF; Tahara S; Naganuma T; Takagi K; Yabushita H; Wang W; Tanaka K; Matsumoto T; Kawamoto H; Yamada Y; Amano S; Watanabe Y; Warisawa T; Sato T; Mitomo S; Kurita N; Ishiguro H; Hozawa K; Tsukahara T; Motosuke M; Bezerra HG; Nakamura S; Nakamura S
Int J Cardiol; 2017 Mar; 230():284-292. PubMed ID: 28065691
[TBL] [Abstract][Full Text] [Related]
3. Angiographic patterns of drug-eluting stent restenosis after treatment with drug-coated balloon versus balloon angioplasty: Late lumen loss subgroup analyses of the PEPCAD-DES study.
Rittger H; Wöhrle J; Brachmann J; Hohenforst-Schmidt W; Schlundt C; Lonke S; von Cranach M; Markovic S; Achenbach S; Waliszewski M
Catheter Cardiovasc Interv; 2016 Oct; 88(4):529-534. PubMed ID: 26893095
[TBL] [Abstract][Full Text] [Related]
4. Subintimal Crush of an Occluded Stent to Recanalize a Chronic Total Occlusion Due to In-Stent Restenosis: Insights From a Multimodality Imaging Approach.
Capretti G; Mitomo S; Giglio M; Carlino M; Colombo A; Azzalini L
JACC Cardiovasc Interv; 2017 Apr; 10(8):e81-e83. PubMed ID: 28365267
[No Abstract] [Full Text] [Related]
5. Multiple Mechanisms in 1 In-Stent Restenosis Assessed by Optical Coherence Tomography.
Lu WD; Huang CW; Li YH; Chen JY
JACC Cardiovasc Interv; 2017 Nov; 10(22):2340-2341. PubMed ID: 29102578
[No Abstract] [Full Text] [Related]
6. Impact of coronary anatomy and stenting technique on long-term outcome after drug-eluting stent implantation for unprotected left main coronary artery disease.
Tiroch K; Mehilli J; Byrne RA; Schulz S; Massberg S; Laugwitz KL; Vorpahl M; Seyfarth M; Kastrati A;
JACC Cardiovasc Interv; 2014 Jan; 7(1):29-36. PubMed ID: 24332416
[TBL] [Abstract][Full Text] [Related]
7. Neointima and neoatherosclerotic characteristics in bare metal and first- and second-generation drug-eluting stents in patients admitted with cardiovascular events attributed to stent failure: an optical coherence tomography study.
Stettler R; Dijkstra J; Räber L; Torii R; Zhang YJ; Karanasos A; Lui S; Crake T; Hamshere S; Garcia-Garcia HM; Tenekecioglu E; Ozkor M; Windecker S; Serruys PW; Regar E; Mathur A; Bourantas CV
EuroIntervention; 2018 Feb; 13(15):e1831-e1840. PubMed ID: 28606888
[TBL] [Abstract][Full Text] [Related]
8. Very Late Restenosis Following Bioresorbable Scaffold Implantation.
Okuno T; Yahagi K; Horiuchi Y; Aoki J; Simonton CA; Rapoza R; Saito S; Kimura T; Tanabe K
JACC Cardiovasc Interv; 2017 Sep; 10(18):e167-e169. PubMed ID: 28866033
[No Abstract] [Full Text] [Related]
9. Comparison between drug-coated balloon angioplasty and second-generation drug-eluting stent placement for the treatment of in-stent restenosis after drug-eluting stent implantation.
Kang IS; Shehata I; Shin DH; Kim JS; Kim BK; Ko YG; Choi D; Jang Y; Hong MK
Heart Vessels; 2016 Sep; 31(9):1405-11. PubMed ID: 26337620
[TBL] [Abstract][Full Text] [Related]
10. Three- and 6-month optical coherence tomographic surveillance following percutaneous coronary intervention with the Angiolite® drug-eluting stent: The ANCHOR study.
Puri R; Otaegui I; Sabaté M; Serra-Peñaranda A; Puigfel M; Perez de Prado A; Nombela-Franco L; de la Torre Hernandez JM; Ortas Nadal R; Iniguez-Romo A; Jiménez G; Fernandez-Vazquez F; Cuellas-Ramon C; Gonzalo N; Alfonso Jiménez Diaz V; Duocastella L; Molina M; Amoros M; Perez I; Barria Perez A; Pelletier Beaumont E; Nicholls SJ; Garcia Del Blanco B; Rodés-Cabau J
Catheter Cardiovasc Interv; 2018 Feb; 91(3):435-443. PubMed ID: 28707379
[TBL] [Abstract][Full Text] [Related]
11. Challenging treatment of in-stent restenosis in a coronary bifurcation by implantation of a bioresorbable scaffold under optical coherence tomography guidance.
Zuk G; Ciecwierz D; Drewla P; Gruchała M; Gutiérrez-Chico JL; Jaguszewski M
Cardiol J; 2019; 26(3):304-306. PubMed ID: 31246271
[No Abstract] [Full Text] [Related]
12. Neointimal Modification With Scoring Balloon and Efficacy of Drug-Coated Balloon Therapy in Patients With Restenosis in Drug-Eluting Coronary Stents: A Randomized Controlled Trial.
Kufner S; Joner M; Schneider S; Tölg R; Zrenner B; Repp J; Starkmann A; Xhepa E; Ibrahim T; Cassese S; Fusaro M; Ott I; Hengstenberg C; Schunkert H; Abdel-Wahab M; Laugwitz KL; Kastrati A; Byrne RA;
JACC Cardiovasc Interv; 2017 Jul; 10(13):1332-1340. PubMed ID: 28683939
[TBL] [Abstract][Full Text] [Related]
13. Serial assessment of vessel interactions after drug-eluting stent implantation in unprotected distal left main coronary artery disease using frequency-domain optical coherence tomography.
Fujino Y; Attizzani GF; Bezerra HG; Wang W; Tahara S; Yamamoto H; Chamie D; Kanaya T; Mehanna E; Takagi K; Nakamura S; Costa MA
JACC Cardiovasc Interv; 2013 Oct; 6(10):1035-45. PubMed ID: 24156964
[TBL] [Abstract][Full Text] [Related]
14. The wound healing response after implantation of a drug-eluting stent is impaired persistently in the long term.
Nasuno T; Tokura M; Kageyama M; Toyoda S; Sakuma M; Komatsu T; Taguchi I; Abe S; Inoue T
Heart Vessels; 2016 Jun; 31(6):985-9. PubMed ID: 25939630
[TBL] [Abstract][Full Text] [Related]
15. Single-stent crossover technique from distal unprotected left main coronary artery to the left circumflex artery.
Naganuma T; Chieffo A; Basavarajaiah S; Takagi K; Costopoulos C; Latib A; Carlino M; Montorfano M; Bernelli C; Nakamura S; Colombo A
Catheter Cardiovasc Interv; 2013 Nov; 82(5):757-64. PubMed ID: 23674385
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of Early Healing Profile and Neointimal Transformation Over 24 Months Using Longitudinal Sequential Optical Coherence Tomography Assessments and 3-Year Clinical Results of the New Dual-Therapy Endothelial Progenitor Cell Capturing Sirolimus-Eluting Combo Stent: The EGO-Combo Study.
Lee SW; Lam SC; Tam FC; Chan KK; Shea CP; Kong SL; Wong AY; Yung A; Zhang LW; Tse HF; Wu KK; Chan R; Haude M; Mehran R; Mintz GS; Maehara A
Circ Cardiovasc Interv; 2016 Jul; 9(7):. PubMed ID: 27418609
[TBL] [Abstract][Full Text] [Related]
17. Association of morphologic characteristics on optical coherence tomography and angiographic progression patterns of late restenosis after drug-eluting stent implantation.
Yamaguchi H; Arikawa R; Takaoka J; Miyamura A; Atsuchi N; Ninomiya T; Atsuchi Y; Ohishi M; Terashima M; Kaneda H
Cardiovasc Revasc Med; 2015; 16(1):32-5. PubMed ID: 25617940
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel-coated balloon for the treatment of drug-eluting stent restenosis: subanalysis results from the Valentines I trial.
Loh JP; Stella PR; Sangiorgi G; Silber S; Stahnke S; von Strandmann RP; Torguson R; Waksman R
Cardiovasc Revasc Med; 2014 Jan; 15(1):23-8. PubMed ID: 24444473
[TBL] [Abstract][Full Text] [Related]
19. Unusually aggressive immature neo-intimal hyperplasia causing in-stent restenosis.
McCutcheon K; Triantafyllis AS; Bennett J; Adriaenssens T
Cardiovasc J Afr; 2017 Nov/Dec 23; 28(6):404-405. PubMed ID: 29019519
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of a seal-wing paclitaxel-eluting balloon catheters in the treatment of bare metal stent restenosis.
Pleva L; Kukla P; Zapletalova J; Hlinomaz O
BMC Cardiovasc Disord; 2017 Jun; 17(1):168. PubMed ID: 28651572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
